| 1 |
Broad L, Lee T, Conroy M, et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 2007;98:19-22.
DOI
|
| 2 |
Bigalke B, Seizer P, Geisler T, Lindemann S, Gawaz M, May AE. Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery. Clin Res Cardiol 2009;98:335-339.
DOI
|
| 3 |
Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery: a prospective outcome study. Br J Anaesth 2006; 96:686-693.
DOI
ScienceOn
|
| 4 |
Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
DOI
ScienceOn
|
| 5 |
Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeleluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-678.
DOI
ScienceOn
|
| 6 |
Baran KW, Lasala JM, Cox DA, et al. A clinical risk score for prediction of stent thrombosis. Am J Cardiol 2008;102: 541-545.
DOI
ScienceOn
|
| 7 |
Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular preventioncardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation- review and meta-analysis. J Intern Med 2005;257:399-414.
DOI
ScienceOn
|
| 8 |
Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL. Coronary artery stents: II. Perioperative considerations and management. Anesth Analg 2008;107: 570-590.
DOI
ScienceOn
|
| 9 |
Samama CM, Thiry D, Elalamy I, et al. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 2001;94:74-78.
DOI
ScienceOn
|
| 10 |
Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004;63:141-145.
DOI
ScienceOn
|
| 11 |
Abualsaud AO, Eisenberg MJ. Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010;3:131-142.
DOI
ScienceOn
|
| 12 |
Schouten O, Bax JJ, Damen J, Poldermans D. Coronary artery stent placement immediately before noncardiac surgery: a potential risk? Anesthesiology 2007;106:1067- 1069.
DOI
ScienceOn
|
| 13 |
Van Kuijk JP, Flu WJ, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009;104: 1229-1234.
DOI
ScienceOn
|
| 14 |
Payne DA, Hayes PD, Jones CI, Belham P, Naylor AR, Goodall AH. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J Vasc Surg 2002;35: 1204-1209.
DOI
ScienceOn
|
| 15 |
Llau JV, Ferrandis R, Sierra P, Gomez-Luque A. Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update. Vasc Health Risk Manag 2010;6:855-867.
|
| 16 |
Samama CM. Preoperative nonsteroidal antiinflammatory agents as substitutes for aspirin: already too late? Anesthesiology 2007;106:205-206.
DOI
ScienceOn
|
| 17 |
Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293: 2126-2130.
DOI
ScienceOn
|
| 18 |
Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-1671.
DOI
ScienceOn
|
| 19 |
Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159-168.
DOI
ScienceOn
|
| 20 |
Park SJ, Park DW, Kim YH, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med 2010;362:1374-1382.
DOI
ScienceOn
|
| 21 |
Park KW, Lee JM, Kang SH, et al. Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTEKorea registries. J Am Coll Cardiol 2013;61:536-544.
DOI
ScienceOn
|
| 22 |
Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-1322.
DOI
ScienceOn
|
| 23 |
Artang R, Dieter R. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries. Am J Cardiol 2007;99:1039-1043.
DOI
ScienceOn
|
| 24 |
Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99:316-328.
DOI
ScienceOn
|
webmaster
